SAN ANTONIO, Oct. 27, 2026 – An Upper-South region of Texas including San Antonio and Bexar County had the state's highest hysterectomy-corrected incidence of endometrial cancer and the largest increase over time, a study led by scientists at The University of Texas at San Antonio Health Science Center and the National Cancer Institute showed.
Endometrial cancer is the most common gynecologic cancer in the United States. And while several types of cancer are declining across the country, endometrial cancer is on the rise, especially in South Texas.
This type of cancer often is diagnosed early and is highly survivable, but both endometrial cancer incidence and mortality rates have increased sharply over the past 20 years. The recent study published in the journal Cancer Epidemiology provides a comprehensive examination of regional differences in endometrial cancer incidence and survival across Texas.
Principal investigator Edward R. Kost, MD, professor of gynecologic oncology in the Department of Obstetrics and Gynecology at the Long School of Medicine and gynecologic oncologist at the Mays Cancer Center at UT Health San Antonio , said the goal is to figure out why endometrial cancer rates are rising and which populations are most affected.
"The mission of the Mays Cancer Center is to reduce the burden of cancer in San Antonio, South Texas and beyond," Kost said. "To do that, we need to understand the cancers that affect our local population."
Rates highest in Upper-South Texas
The research team analyzed population-based data from 42,571 Texas women ages 20 to 79 with endometrial cancer who were diagnosed between 2000 and 2019 using the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. The analysis compared eight Texas Health Service Regions.
It showed an Upper-South region including San Antonio and Bexar County with the highest hysterectomy-corrected incidence in the state and the largest increase over time, rising from 42.6 per 100,000 women in 2000-2009 to 53.8 per 100,000 in 2010-2019.
The study found that among women under age 50, Hispanic women had the highest incidence of endometrial cancer compared to other groups included in the study.
Among women under age 50, the statewide hysterectomy-corrected incidence rate was 12.4 per 100,000 among Hispanic women, compared with 8.9 among non-Hispanic white women and 5.6 among non-Hispanic Black women. In the Upper-South region, the early-onset incidence among Hispanic women reached 17.2 per 100,000.
The study also found that non-Hispanic Black women had higher rates of non-endometrioid tumors – the more aggressive form of this cancer – and poorer five-year relative survival.
"Part of our responsibility is to understand the cancer burden of the population we serve, and we found cancer disparities that are affecting our community," Kost said.
Increased cancer rates in younger women
A major concern is the high rates of endometrial cancer in younger women in Texas.
"Our institutional tumor registry data from Bexar County suggest that approximately 25% of endometrial cancer patients were younger than 50 years at diagnosis, compared with approximately 15% nationally," Kost said.
The most common treatment for endometrial cancer is hysterectomy, the surgical removal of the uterus.
For carefully selected women with early endometrial cancer who want to preserve fertility, more conservative treatment options are available. These can include progestin therapy, often with an intrauterine device, close endometrial surveillance with repeat biopsies and efforts to address obesity and other metabolic risk factors, diet modification, exercise and consideration of weight reduction with GLP-1 medications or bariatric surgery when appropriate.
Even when the cancer is successfully controlled and fertility is preserved, achieving pregnancy can present challenges. Many women may need to see a reproductive endocrinologist. The process can be grueling, expensive and not always successful.
"Wanting to have a child is one of the strongest desires a human can have," Kost said. "We do everything we can to preserve a woman's ability to have children, but there are so many hurdles, and the primary goal is to get the cancer into remission."
Finding the risk factors
Kost said the research team hopes to study population-level differences at a more granular level to better understand factors that may contribute to the observed disparities.
One of the greatest risk factors for endometrial cancer is increased body mass index (BMI). While scientists are still working to understand why endometrial cancer rates are increasing, rates of early onset endometrioid cancer have risen in parallel with increasing rates of obesity.
BMI and individual-level metabolic factors, such as obesity, diabetes, hypertension and fatty liver disease, were not available variables in the SEER data used for this study.
This initial study identifies the problem, and the next step in the research is a closer look at metabolic factors, social determinants of health, geographic differences and other known risk factors in the Upper-South region to see where there is overlap with endometrial cancer rates.
Geospatial analysis to connect the dots
Kost said the team plans to use geospatial analysis to examine how cancer rates overlap with various risk factors across populations.
"We want to understand how cancer incidence and potential risk factors overlap at a much more local level, including census-tract-level geography," he said. "That would allow us to focus community interventions in the areas where they may be needed most."
One of the strengths of the study is the collaborative team that brought together expertise in cancer epidemiology, population health, cancer biology and the gynecologic oncology group.
"Ultimately, the purpose is to move from identifying disparities to understanding their causes and developing better prevention, early detection, outreach and care," Kost said.
Regional and Statewide Hysterectomy-Corrected Endometrial Cancer Incidence and Five-Year Relative Survival in Texas
Akemi T. Wijayabahu, Nicolas Wentzensen, Nameer B. Kirma, Lillian Lin-Smith, Wayne R. Lawrence, Chen-Pin Wang, Edward R. Kost
Published July 20, 2026, in Cancer Epidemiology
Link to full study: https://pmc.ncbi.nlm.nih.gov/articles/PMC13528401/
The Joe R. and Teresa Lozano Long School of Medicine at The University of Texas at San Antonio (UT San Antonio) is listed among U.S. News & World Report's best medical schools, among the top 5% of universities globally for clinical medicine research and ranked as the third-highest medical school in Texas for medical research funding by the National Institutes of Health. The Long School of Medicine supports the university's academic health center, UT Health San Antonio.
The Mays Cancer Center at UT Health San Antonio is one of only four National Cancer Institute-designated Cancer Centers in Texas. The Mays Cancer Center provides leading-edge cancer care, propels innovative cancer research, and educates the next generation of leaders to end cancer in South Texas. Mays Cancer Center has a clinical partnership with MD Anderson Cancer Center, expanding access to cancer treatments that are among the most advanced in the nation – close to home. UT Health San Antonio is the academic health center of The University of Texas at San Antonio (UT San Antonio). To learn more, visit https://cancer.uthscsa.edu .
Stay connected with the Mays Cancer Center on Facebook , Twitter
